得利斯(002330.SZ):與益生股份、舜騰投資簽署戰略合作協議
格隆匯10月10日丨得利斯(002330.SZ)公佈,近日,公司與山東益生種畜禽股份有限公司(“益生股份”)、濟南舜騰股權投資管理有限公司(“舜騰投資”)簽署了《戰略合作協議》,三方資源優勢互補,助推生豬全產業鏈合作項目,為推動農村一二三產業融合貢獻力量。
此次《戰略合作協議》簽署,將進一步穩定公司生豬原材料的供應,擴大肉製品深加工產業規模,把握市場機遇,完善市場佈局,提高產品認知度和市場佔有率。後續,公司將以現代農業為依託,與益生股份、舜騰投資共同致力於生豬全產業鏈發展,通過產業鏈延伸、產業融合、機制創新等方式,發揮三方的產業鏈整合優勢,優化資源配置,推動長期、穩定、全面的多領域合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.